Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of SOD1 Inhibition by Pyrimethamine in Familial ALS

NCT01083667 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT01083667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01083667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of SOD1 Inhibition by Pyrimethamine in Familial ALS
Lead sponsor
Weill Medical College of Cornell University
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2009
Completion date
May 31, 2016
Enrollment
32 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

familial amyotrophic lateral sclerosis